Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect (ATAX)
Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect (ATAX)
Sponsor: Oregon Health and Science University
Terminated
Low enrollment
Other terminated trials from Oregon Health and Science University
- Movement Disorders · May 2021
- Maternal Psychological Distress · Phase NA · Mar 2021
- Dyskinesias · Phase PHASE1 · Feb 2021
- Bell Palsy · Phase NA · Aug 2020
- Contraception · Phase NA · Jun 2017
See all terminations from Oregon Health and Science University
Listed as NCT03769961, this observational or N/A phase trial focuses on Ataxia and Cerebellar Diseases and remains terminated or withdrawn. Sponsored by Oregon Health and Science University, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Oct 2020 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jan 2020 — Oct 2020 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jan 2019 — Jan 2020 [monthly]
Recruiting
First recorded
Dec 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oregon Health and Science University
- Portland VA Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .